Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Signal Transduction and Targeted Therapy
|
August 12, 2022
Engineered virus-like particles: paving the way for effective somatic genome editing
Chenya Zhuo, Yu Tao, Mingqiang Li
Water Research
|
March 2, 2020
Effects of the structures and micropores of sedimentary organic matter on the oxidative degradation of benzo(a)pyrene by Na<sub>2</sub>S<sub>2</sub>O<sub>8</sub>
Chenya Zhuo, Shujie Hu, Yu Yang, et al.
Water Research
|
May 24, 2019
Effects of compositions, chemical structures, and microporosity of sedimentary organic matter on degradation of benzo(a)pyrene by hydrogen peroxide
Chenya Zhuo, Dainan Zhang, Yu Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 21, 2024
3D Printing of a Vascularized Mini-Liver Based on the Size-Dependent Functional Enhancements of Cell Spheroids for Rescue of Liver Failure
Jiabin Zhang, Xiaodie Chen, Yurong Chai, et al.
Biomaterials Science
|
May 29, 2024
Functionalized extracellular nanovesicles as advanced CRISPR delivery systems
Siqing Wang, Huimin Kong, Chenya Zhuo, et al.
Signal Transduction and Targeted Therapy
|
June 20, 2021
Spatiotemporal control of CRISPR/Cas9 gene editing
Chenya Zhuo, Jiabin Zhang, Jung-Hwan Lee, et al.
Medical Oncology (Northwood, London, England)
|
January 4, 2022
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway
Li Liu, Changyan Liang, Chenya Zhuo, et al.
Biomaterials
|
January 29, 2023
Highly efficient fabrication of functional hepatocyte spheroids by a magnetic system for the rescue of acute liver failure
Jiabin Zhang, Yanteng Xu, Chenya Zhuo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2025
Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade
Huimin Kong, Siqing Wang, Chenya Zhuo, et al.
Clinical Immunology (Orlando, Fla.)
|
May 30, 2025
PD-1 monoclonal antibody (Tislelizumab)-induced DRESS syndrome in an intrahepatic cholangiocarcinoma patient with FGFR3 mutation and elevated IgG4:A case report
Wei Qin, Xiaoying Wu, Qiongyuan Xu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Signal Transduction and Targeted Therapy
|
August 12, 2022
Engineered virus-like particles: paving the way for effective somatic genome editing
Chenya Zhuo, Yu Tao, Mingqiang Li
Water Research
|
March 2, 2020
Effects of the structures and micropores of sedimentary organic matter on the oxidative degradation of benzo(a)pyrene by Na<sub>2</sub>S<sub>2</sub>O<sub>8</sub>
Chenya Zhuo, Shujie Hu, Yu Yang, et al.
Water Research
|
May 24, 2019
Effects of compositions, chemical structures, and microporosity of sedimentary organic matter on degradation of benzo(a)pyrene by hydrogen peroxide
Chenya Zhuo, Dainan Zhang, Yu Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 21, 2024
3D Printing of a Vascularized Mini-Liver Based on the Size-Dependent Functional Enhancements of Cell Spheroids for Rescue of Liver Failure
Jiabin Zhang, Xiaodie Chen, Yurong Chai, et al.
Biomaterials Science
|
May 29, 2024
Functionalized extracellular nanovesicles as advanced CRISPR delivery systems
Siqing Wang, Huimin Kong, Chenya Zhuo, et al.
Signal Transduction and Targeted Therapy
|
June 20, 2021
Spatiotemporal control of CRISPR/Cas9 gene editing
Chenya Zhuo, Jiabin Zhang, Jung-Hwan Lee, et al.
Medical Oncology (Northwood, London, England)
|
January 4, 2022
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway
Li Liu, Changyan Liang, Chenya Zhuo, et al.
Biomaterials
|
January 29, 2023
Highly efficient fabrication of functional hepatocyte spheroids by a magnetic system for the rescue of acute liver failure
Jiabin Zhang, Yanteng Xu, Chenya Zhuo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2025
Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade
Huimin Kong, Siqing Wang, Chenya Zhuo, et al.
Clinical Immunology (Orlando, Fla.)
|
May 30, 2025
PD-1 monoclonal antibody (Tislelizumab)-induced DRESS syndrome in an intrahepatic cholangiocarcinoma patient with FGFR3 mutation and elevated IgG4:A case report
Wei Qin, Xiaoying Wu, Qiongyuan Xu, et al.
Page
of 2